Abstract
Clinical Benefit of Crenolanib, with or without Salvage Chemotherapy, in Multiply Relapsed, FLT3 Mutant AML Patients after Prior Treatment with Gilteritinib
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have